w standard for rational drug design The principals invested S2.3M (Fully-Diluted Equity Ownership: —7.0%) in November 2012. Other Investors include Atlas Venture, SR One, Lilly Ventures and Schrodinger (9.5%). Research Gate ResearchCate is developing a social networking site for the research scientist commun

es on investments in the consumer Internet and digital media sectors, since April 2008. Prior to her tenure at Accel. Ms. De Rycker was a Partner at Atlas Venture in London from August 2000 to April 2008, where she focused on investments in the internet and software service sectors. Prior to her venture capita